Which of the following biochemical changes is not indicative of hyperlipidemia type II-A:
**Core Concept**
Hyperlipidemia type II-A, also known as familial hypercholesterolemia (FH), is a genetic disorder characterized by elevated levels of low-density lipoprotein (LDL) cholesterol. This condition is caused by mutations in the LDL receptor gene, leading to impaired clearance of LDL cholesterol from the bloodstream.
**Why the Correct Answer is Right**
The biochemical changes indicative of hyperlipidemia type II-A include increased levels of LDL cholesterol and decreased levels of high-density lipoprotein (HDL) cholesterol. This is due to the impaired function of LDL receptors, which normally facilitate the uptake and clearance of LDL cholesterol from the bloodstream. As a result, LDL cholesterol levels accumulate in the blood, leading to the development of atherosclerotic plaques and increased risk of cardiovascular disease.
**Why Each Wrong Option is Incorrect**
* **Option A:** Elevated triglycerides are a characteristic feature of hyperlipidemia type II-B, not type II-A. This option is incorrect because type II-A is primarily associated with elevated LDL cholesterol levels, not triglycerides.
* **Option B:** Decreased LDL receptor activity is a hallmark of hyperlipidemia type II-A, making this option incorrect.
* **Option D:** Increased levels of very-low-density lipoprotein (VLDL) cholesterol are not a primary feature of hyperlipidemia type II-A, making this option incorrect.
**Clinical Pearl / High-Yield Fact**
Familial hypercholesterolemia (FH) is a genetic disorder that affects approximately 1 in 200 individuals worldwide. Early diagnosis and treatment are crucial to prevent the development of atherosclerotic cardiovascular disease.
**Correct Answer:** A. Elevated triglycerides